{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2018:PDLZRTCA7Q7QFOCZ3QLLNJ3M5M","short_pith_number":"pith:PDLZRTCA","canonical_record":{"source":{"id":"1805.01834","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.OT","submitted_at":"2018-05-04T16:03:37Z","cross_cats_sorted":[],"title_canon_sha256":"0331c2ddd8de117a02e27acf2d7abadac8f64c09af2c590551f77f0b91cba28c","abstract_canon_sha256":"3d7418bb78cdba311fff919f2d248a14d1570ed1ebc9c8a8456c77f188dbb005"},"schema_version":"1.0"},"canonical_sha256":"78d798cc40fc3f02b859dc16b6a76ceb001b4f38645b95d8dff0bd794dfcfb7c","source":{"kind":"arxiv","id":"1805.01834","version":2},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1805.01834","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"arxiv_version","alias_value":"1805.01834v2","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1805.01834","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"pith_short_12","alias_value":"PDLZRTCA7Q7Q","created_at":"2026-05-18T12:32:43Z"},{"alias_kind":"pith_short_16","alias_value":"PDLZRTCA7Q7QFOCZ","created_at":"2026-05-18T12:32:43Z"},{"alias_kind":"pith_short_8","alias_value":"PDLZRTCA","created_at":"2026-05-18T12:32:43Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2018:PDLZRTCA7Q7QFOCZ3QLLNJ3M5M","target":"record","payload":{"canonical_record":{"source":{"id":"1805.01834","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.OT","submitted_at":"2018-05-04T16:03:37Z","cross_cats_sorted":[],"title_canon_sha256":"0331c2ddd8de117a02e27acf2d7abadac8f64c09af2c590551f77f0b91cba28c","abstract_canon_sha256":"3d7418bb78cdba311fff919f2d248a14d1570ed1ebc9c8a8456c77f188dbb005"},"schema_version":"1.0"},"canonical_sha256":"78d798cc40fc3f02b859dc16b6a76ceb001b4f38645b95d8dff0bd794dfcfb7c","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:05:14.103632Z","signature_b64":"P2bodJYctwvswTvKL8z9qr25eYKJYaERwbwm4gFdfF8+xrpZrtqQ0VX6VCZdtmsOZkcgwqYq0mhUTvQPed0rAg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"78d798cc40fc3f02b859dc16b6a76ceb001b4f38645b95d8dff0bd794dfcfb7c","last_reissued_at":"2026-05-18T00:05:14.103080Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:05:14.103080Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1805.01834","source_version":2,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:05:14Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"fyqWDFwo7ZY7UsvJAnuyOaNp7P5UVurQT3uGhN4VsxYG1XOfMjSKebjXUKVkkovf46SO2L3xW0Yt8hfYKLr5Cw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-07T00:22:14.144585Z"},"content_sha256":"c98c05ab1bcf89b5dfcb57f5000fac58f55e573f5bbdd153998a0c9f267abc1f","schema_version":"1.0","event_id":"sha256:c98c05ab1bcf89b5dfcb57f5000fac58f55e573f5bbdd153998a0c9f267abc1f"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2018:PDLZRTCA7Q7QFOCZ3QLLNJ3M5M","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.OT","authors_text":"Anja Loos, Carsten Schwenke, Claudia Ose, Claudia Schmoor, Dietrich Knoerzer, Florian Voss, Frank Langer, Friedhelm Leverkus, Guido Skipka, Jan Beyersmann, Katrin Kupas, Kristina Unnebrink, Marjan Amiri, Norbert Benda, Steffen Unkel, Tanja Proctor, Tim Friede","submitted_at":"2018-05-04T16:03:37Z","abstract_excerpt":"The analysis of adverse events (AEs) is a key component in the assessment of a drug's safety profile. Inappropriate analysis methods may result in misleading conclusions about a therapy's safety and consequently its benefit-risk ratio. The statistical analysis of AEs is complicated by the fact that the follow-up times can vary between the patients included in a clinical trial. This paper takes as its focus the analysis of AE data in the presence of varying follow-up times within the benefit assessment of therapeutic interventions. Instead of approaching this issue directly and solely from an a"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1805.01834","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:05:14Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"kGPWnFmKBDKuNd1PglMR891AlJRZNavlK33HJZQ1yF/6171qmGUiiNffCp1HF+fYXXzLJ5Xan0hvzZn3DBJUBA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-07T00:22:14.145275Z"},"content_sha256":"864ca70dedbcc7ab7e3a22bdef18db18b1af8c2133c1bf97ae4fd7ac37689cb1","schema_version":"1.0","event_id":"sha256:864ca70dedbcc7ab7e3a22bdef18db18b1af8c2133c1bf97ae4fd7ac37689cb1"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/bundle.json","state_url":"https://pith.science/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-07T00:22:14Z","links":{"resolver":"https://pith.science/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M","bundle":"https://pith.science/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/bundle.json","state":"https://pith.science/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/state.json","well_known_bundle":"https://pith.science/.well-known/pith/PDLZRTCA7Q7QFOCZ3QLLNJ3M5M/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2018:PDLZRTCA7Q7QFOCZ3QLLNJ3M5M","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"3d7418bb78cdba311fff919f2d248a14d1570ed1ebc9c8a8456c77f188dbb005","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.OT","submitted_at":"2018-05-04T16:03:37Z","title_canon_sha256":"0331c2ddd8de117a02e27acf2d7abadac8f64c09af2c590551f77f0b91cba28c"},"schema_version":"1.0","source":{"id":"1805.01834","kind":"arxiv","version":2}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1805.01834","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"arxiv_version","alias_value":"1805.01834v2","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1805.01834","created_at":"2026-05-18T00:05:14Z"},{"alias_kind":"pith_short_12","alias_value":"PDLZRTCA7Q7Q","created_at":"2026-05-18T12:32:43Z"},{"alias_kind":"pith_short_16","alias_value":"PDLZRTCA7Q7QFOCZ","created_at":"2026-05-18T12:32:43Z"},{"alias_kind":"pith_short_8","alias_value":"PDLZRTCA","created_at":"2026-05-18T12:32:43Z"}],"graph_snapshots":[{"event_id":"sha256:864ca70dedbcc7ab7e3a22bdef18db18b1af8c2133c1bf97ae4fd7ac37689cb1","target":"graph","created_at":"2026-05-18T00:05:14Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"The analysis of adverse events (AEs) is a key component in the assessment of a drug's safety profile. Inappropriate analysis methods may result in misleading conclusions about a therapy's safety and consequently its benefit-risk ratio. The statistical analysis of AEs is complicated by the fact that the follow-up times can vary between the patients included in a clinical trial. This paper takes as its focus the analysis of AE data in the presence of varying follow-up times within the benefit assessment of therapeutic interventions. Instead of approaching this issue directly and solely from an a","authors_text":"Anja Loos, Carsten Schwenke, Claudia Ose, Claudia Schmoor, Dietrich Knoerzer, Florian Voss, Frank Langer, Friedhelm Leverkus, Guido Skipka, Jan Beyersmann, Katrin Kupas, Kristina Unnebrink, Marjan Amiri, Norbert Benda, Steffen Unkel, Tanja Proctor, Tim Friede","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.OT","submitted_at":"2018-05-04T16:03:37Z","title":"On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1805.01834","kind":"arxiv","version":2},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:c98c05ab1bcf89b5dfcb57f5000fac58f55e573f5bbdd153998a0c9f267abc1f","target":"record","created_at":"2026-05-18T00:05:14Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"3d7418bb78cdba311fff919f2d248a14d1570ed1ebc9c8a8456c77f188dbb005","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.OT","submitted_at":"2018-05-04T16:03:37Z","title_canon_sha256":"0331c2ddd8de117a02e27acf2d7abadac8f64c09af2c590551f77f0b91cba28c"},"schema_version":"1.0","source":{"id":"1805.01834","kind":"arxiv","version":2}},"canonical_sha256":"78d798cc40fc3f02b859dc16b6a76ceb001b4f38645b95d8dff0bd794dfcfb7c","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"78d798cc40fc3f02b859dc16b6a76ceb001b4f38645b95d8dff0bd794dfcfb7c","first_computed_at":"2026-05-18T00:05:14.103080Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:05:14.103080Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"P2bodJYctwvswTvKL8z9qr25eYKJYaERwbwm4gFdfF8+xrpZrtqQ0VX6VCZdtmsOZkcgwqYq0mhUTvQPed0rAg==","signature_status":"signed_v1","signed_at":"2026-05-18T00:05:14.103632Z","signed_message":"canonical_sha256_bytes"},"source_id":"1805.01834","source_kind":"arxiv","source_version":2}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:c98c05ab1bcf89b5dfcb57f5000fac58f55e573f5bbdd153998a0c9f267abc1f","sha256:864ca70dedbcc7ab7e3a22bdef18db18b1af8c2133c1bf97ae4fd7ac37689cb1"],"state_sha256":"b392c1b1a6aab3d9e0735519c871a310a244f0e9b0ae052b5fd226e88b5ba4f6"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"IFlg+c8OJzECQ+qcBUi8rh7vuwYjv/F59jkY1V2lL1XFtf9tWwSL5UJbtXN2WHObuVjgWda5/F9pPEUl3ZhcDQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-07T00:22:14.149821Z","bundle_sha256":"26cd96636b27c538b2c93e0afcd192f484b6a4a3bf081a0a768aafac9be51b93"}}